Medically reviewed by. Last updated on Mar 23, 2025.
Crestor is a prescription medication used to lower LDL-C levels, which is the “bad” cholesterol. It belongs to a class of drugs known as “bad” cholesterol-reducing drugs (B-EDPs).
The primary use of Crestor is to lower LDL-C levels, which is a "good" cholesterol (good for the heart) and a “danger" cholesterol (danger for the liver). It can be used alone or in combination with other medications (prescription or over-the-counter).
Crestor should be used with a reduced-calorie diet, exercise, and/or weight-loss program before you use it. Avoid consuming fatty foods, including animal products, including meat, fish, and shellfish. Drink plenty of water while using Crestor to ensure proper functioning of your kidneys.
It is not recommended to take Crestor more often than every day. If you have any medical conditions, check with your doctor. You should not use Crestor if you are pregnant or breast-feeding.
Crestor works by blocking the enzyme HMG-CoA reductase, which is responsible for making cholesterol in the body more efficient for building new blood cells. This causes the liver to reduce levels of LDL-C to LDL-C levels, which is an “available” cholesterol, and more efficient for making a lot of fat cells that you do not need to be fat. By lowering LDL-C, Crestor lowers the "bad" cholesterol and the “danger” cholesterol levels.
Crestor is typically taken once or twice daily. It can be taken with or without food. You should take the medication at least one hour before you plan to have sex. To ensure the medication reaches your bloodstream, take it at the same time every day.
There are with Crestor. The main interaction is with alcohol, as well. Moderate alcohol consumption can decrease the effectiveness of Crestor. Limit alcohol to avoid excessive alcohol consumption and use caution when using this medication with certain medications (eg, nitrates, certain drugs used to treat HIV).
Crestor should not be used for any purpose other than that listed in the patient information leaflet. Consult your doctor or pharmacist before using Crestor in the following cases:
If you have any medical conditions, take any medications, or are taking any medications, tell your doctor before starting oretimes Crestor.
Avoid fatty foods, including animal products, including meat, fish, and shellfish.
AstraZeneca’s cholesterol drug Crestor has been sued by a U. S. District Court judge for refusing to grant AstraZeneca’s motion for summary judgment.
AstraZeneca today filed a motion for summary judgment in the U. District Court for the Eastern District of Virginia, claiming that the district court’s grant of Crestor’s motion in part was improper because the plaintiff had not submitted sufficient evidence to show that Crestor’s drug caused cancer.
Crestor is a cholesterol-lowering medication that has been approved by the U. Food and Drug Administration (FDA) for treating high cholesterol in adults. Crestor is one of a class of drugs called statins. AstraZeneca will also vigorously defend Crestor in federal court in this litigation.
Crestor and AstraZeneca are both subsidiaries of the AstraZeneca Group, a pharmaceutical company that manufactures and markets Crestor in the United States and worldwide. AstraZeneca is the parent company of AstraZeneca Pharmaceuticals Inc., a subsidiary of AstraZeneca AB, a subsidiary of AstraZeneca Pharmaceuticals, Inc., a global pharmaceutical company.
AstraZeneca has made several significant contributions to the pharmaceutical industry. AstraZeneca is one of the world’s leading pharmaceutical companies and is a leading global player in the production, distribution and sales of prescription pharmaceuticals. The company is the world’s largest generic manufacturer of generic drugs.
AstraZeneca’s action against the defendants is based on several allegations of fraudulent conduct involving the conduct of AstraZeneca in connection with the conduct of Crestor and its product. As part of the case, the defendants claim that the district court erred in granting summary judgment in part because the plaintiff had not submitted sufficient evidence to show that Crestor caused cancer.
AstraZeneca will continue to defend Crestor in this litigation against AstraZeneca in a number of other jurisdictions. AstraZeneca will continue to defend Crestor in this litigation in other jurisdictions and will vigorously defend Crestor in this litigation.
AstraZeneca’s motion for summary judgment
AstraZeneca is entitled to all costs and expenses incurred by the district court in this action. As of the date of this decision, AstraZeneca has already paid the costs of this litigation.
The defendants’ motion for summary judgment
The motion for summary judgment alleges that the plaintiff has not submitted sufficient evidence to show that Crestor caused cancer.
AstraZeneca and the defendants have each filed a motion for summary judgment in this case, claiming that the plaintiff has not submitted sufficient evidence to show that Crestor caused cancer. This motion alleges that the defendants have made unsubstantiated claims of harm by not filing a motion for summary judgment.
AstraZeneca and the defendants have also filed a motion for summary judgment in this action. AstraZeneca and the defendants have both argued that summary judgment is not appropriate because there is no adequate state of mind in this case.
AstraZeneca has responded to the defendants’ motion for summary judgment. The plaintiff filed a motion for summary judgment in this case.
AstraZeneca has filed a motion for summary judgment in this case. AstraZeneca has responded to the defendants’ motion for summary judgment in this action.
The defendants’ motion for summary judgment asserts that the plaintiff has not submitted sufficient evidence to support its allegations that Crestor caused cancer. The plaintiff has also filed a motion for summary judgment in this litigation. The plaintiff has not provided sufficient evidence to show that Crestor caused cancer.
AstraZeneca is entitled to all costs and expenses incurred by the district court in this litigation.
AstraZeneca has made numerous arguments in this litigation in support of its motion for summary judgment.
Crestor works by reducing a certain enzyme within the body that produces cholesterol. It belongs to a class of medications called statins.
Cholesterol is a form of lipid, a waxy substance that helps your body make cells, vitamins, and certain hormones. It is not inherently bad. Your liver produces an enzyme that synthesizes cholesterol to help with the above healthy functions. Additional cholesterol is introduced to the body through certain foods like meat, poultry, and dairy products.
There are two types of cholesterol: high-density lipoproteins (HDLs) and low-density lipoproteins (LDLs). LDLs carry cholesterol throughout the body, delivering cholesterol to cells that need it. HDLs carry excess LDLs back to the liver, where they are broken down and flushed from the body. While LDLs play a key role in cell health, they build up when the body has more cholesterol than the cells need. This buildup turns into plaque in the arteries (blood vessels). As plaque covers the artery walls, the blood vessels become narrow. This makes it harder for blood to flow through the body, which can lead to heart disease and heart failure.
Statins work by reducing the production of cholesterol in the liver, which lowers the overall cholesterol levels in the body. Not only do statins decrease levels of LDLs in the body, but they can also raise the level of HDLs in the body. In effect, they keep the body from making too much of the “bad” cholesterol that builds up in arteries while increasing the amount of “good” cholesterol that carries the “bad” out of the body. This dual action has been shown, along with diet and exercise, to lower overall cholesterol levels in patients effectively.
Crestor tablets May be taken Mayby, a risk-taking medicine Mayby may be taken if you are at high risk of getting certain side effects while taking medications. It is not certain whether this medication was specifically designed for Mayby and if it would have any effect on the medication. The side effects of Mayby include:Mayby is not recommended for use in patients with a history of coronary artery disease, as it maya been associated with its effects on cholesterol. If you experience any of these side effects, stop taking this medicine and contact a doctor right away:
Mayby is not recommended for use in patients with a history of coronary artery disease, as it may have a potential risk-related side effect.
Mayby is not recommended for use in patients with a history of coronary artery disease, as it may be associated with a potential risk-related side effect.
The Federal Drug Administration (FDA) approved Crestor (rosuvastatin calcium) in November to treat hypercholesterolemia in adults and adolescents. The approval is expected to remain in effect for at least the next several months.
According to the FDA, Crestor is approved for the treatment of patients with at least one of these conditions, which includes an increased risk of developing an inherited form of the disease. The drug is also used for the treatment of benign prostatic hyperplasia and male pattern baldness.
The FDA also approved the use of Crestor for the treatment of chronic kidney disease (CKD) in adults with reduced kidney function. It is also approved for the treatment of the symptoms of benign prostatic hyperplasia (BPH), which is a common condition in men that affects the urinary system, especially in men who have male-pattern baldness.
The FDA has approved a separate approval to treat cholesterol in adults with elevated levels of high-density lipoprotein (HDL) and to treat high-density lipoprotein (HDL) cholesterol in adults.
The FDA also approved Crestor to treat androgenic alopecia in men with mild to moderate hyperandrogenism, which is an inherited form of the condition. It is also approved for the treatment of androgenic alopecia androgenic alopecia in men with mild to moderate hyperandrogenism.
The FDA has also approved a separate approval for the treatment of benign prostate hyperplasia in adults with normal or decreased urinary flow, to help improve urinary symptoms and to prevent prostate enlargement.
The FDA has also approved a separate approval for the treatment of benign prostatic hypertrophy in men with mild to moderate benign prostatic hyperplasia (BPH) who have an enlarged prostate, to help reduce the need for surgery.
The FDA has approved the use of Crestor in combination with other medications to treat androgenic alopecia.
The FDA has approved a separate approval to treat cholesterol in adults with low-density lipoprotein (LDL) cholesterol, and to treat high-density lipoprotein (HDL) cholesterol in adults with normal or decreased urinary flow.
The FDA has approved a separate approval for the treatment of androgenic alopecia in men with normal or decreased urinary flow, to help improve urinary symptoms and to prevent prostate enlargement.
The FDA has approved a separate approval for the treatment of benign prostatic hyperplasia in adults with normal or decreased urinary flow, to help reduce the need for surgery.
The FDA has approved a separate approval for the treatment of androgenic alopecia in men with normal or decreased urinary flow, to help reduce the need for surgery.
The FDA has approved a separate approval for the treatment of high-density lipoprotein (HDL) cholesterol, to help reduce the need for surgery.
The FDA has approved a separate approval for the treatment of benign prostate hyperplasia in adults with normal or decreased urinary flow, to help reduce the need for surgery.
The FDA has approved a separate approval for the treatment of high blood pressure in adults with at least one of these conditions, to help improve urinary symptoms and to prevent prostate enlargement.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
healthcareylife. (ph). (stock).
Stade de France Pharmacy